147 related articles for article (PubMed ID: 38057203)
41. Residual lymph node tumour burden following removal of a single axillary sentinel lymph with macrometastatic disease in women with screen-detected invasive breast cancer.
Dave RV; Cheung S; Sibbering M; Kearins O; Jenkins J; Gandhi A
BJS Open; 2021 Mar; 5(2):. PubMed ID: 33688940
[TBL] [Abstract][Full Text] [Related]
42. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
43. [A new perspective on axillary dissection in situations of metastatic sentinel node].
Zedníková I; Ňaršanská A; Hes O; Metelková A; Fiala O; Svoboda T
Rozhl Chir; 2017; 96(8):346-352. PubMed ID: 29058925
[TBL] [Abstract][Full Text] [Related]
44. The significance of sentinel lymph node micrometastasis in breast cancer: Comparing outcomes with and without axillary clearance.
Youssef MMG; Cameron D; Pucher PH; Olsen S; Ferguson D
Breast; 2016 Dec; 30():101-104. PubMed ID: 27668857
[TBL] [Abstract][Full Text] [Related]
45. Non-invasive predictors of axillary lymph node burden in breast cancer: a single-institution retrospective analysis.
Ngai V; Tai JCJ; Taj S; Khanfar H; Sfakianakis E; Bakalis A; Baker R; Ahmed M
Breast Cancer Res Treat; 2022 Sep; 195(2):161-169. PubMed ID: 35864309
[TBL] [Abstract][Full Text] [Related]
46. No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial.
Jung JG; Ahn SH; Lee S; Kim EK; Ryu JM; Park S; Lim W; Jung YS; Chung IY; Jeong J; Chang JH; Shin KH; Chang JM; Moon WK; Han W
BMC Cancer; 2022 Feb; 22(1):189. PubMed ID: 35184724
[TBL] [Abstract][Full Text] [Related]
47. Microscopic Extracapsular Extension in Sentinel Lymph Nodes Does Not Mandate Axillary Dissection in Z0011-Eligible Patients.
Barrio AV; Downs-Canner S; Edelweiss M; Van Zee KJ; Cody HS; Gemignani ML; Pilewskie ML; Plitas G; El-Tamer M; Kirstein L; Capko D; Patil S; Morrow M
Ann Surg Oncol; 2020 May; 27(5):1617-1624. PubMed ID: 31820212
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of axillary reverse mapping (ARM) in clinically axillary node negative breast cancer patients - Randomised controlled trial.
Abdelhamid MI; Bari AA; Farid MI; Nour H
Int J Surg; 2020 Mar; 75():174-178. PubMed ID: 32059974
[TBL] [Abstract][Full Text] [Related]
49. Does 'fast - track' axillary node clearance following positive core biopsy lead to overtreatment of axilla?
Abdullah M; Voynov V; Stonelake P
Surgeon; 2021 Jun; 19(3):135-141. PubMed ID: 32444338
[TBL] [Abstract][Full Text] [Related]
50. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
51. A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer.
Beek MA; Gobardhan PD; Klompenhouwer EG; Menke-Pluijmers MB; Steenvoorde P; Merkus JW; Rutten HJ; Voogd AC; Luiten EJ
Eur J Surg Oncol; 2020 Jan; 46(1):59-64. PubMed ID: 31402072
[TBL] [Abstract][Full Text] [Related]
52. Axillary Lymph Node Dissection is Associated with Improved Survival Among Men with Invasive Breast Cancer and Sentinel Node Metastasis.
Chung SH; de Geus SWL; Shewmaker G; Romatoski KS; Drake FT; Ko NY; Merrill AL; Hirsch AE; Tseng JF; Sachs TE; Cassidy MR
Ann Surg Oncol; 2023 Sep; 30(9):5610-5618. PubMed ID: 37204557
[TBL] [Abstract][Full Text] [Related]
53. Arm morbidity of axillary dissection with sentinel node biopsy versus delayed axillary dissection.
Ballal H; Hunt C; Bharat C; Murray K; Kamyab R; Saunders C
ANZ J Surg; 2018 Sep; 88(9):917-921. PubMed ID: 29392828
[TBL] [Abstract][Full Text] [Related]
54. Neoadjuvant chemotherapy and timing of sentinel lymph node biopsy in different molecular subtypes of breast cancer with clinically negative axilla.
Bi Z; Liu J; Chen P; Liu Y; Zhao T; Wang C; Zhang Z; Sun X; Qiu P; Cong B; Song X; Wang Y
Breast Cancer; 2019 May; 26(3):373-377. PubMed ID: 30666563
[TBL] [Abstract][Full Text] [Related]
55. Axillary lymph node clearance in patients with positive sentinel lymph node biopsy.
Hussain T; Kneeshaw PJ
Ann R Coll Surg Engl; 2014 Apr; 96(3):199-201. PubMed ID: 24780783
[TBL] [Abstract][Full Text] [Related]
56. [Identification and preservation of arm lymphatics in axillary lymph node dissection to prevent arm lymphedema: a single center randomized controlled trial].
Yuan QQ; Wu GS; Hou JX; Zheng LW; Liao YQ; He YK
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):430-435. PubMed ID: 35615800
[No Abstract] [Full Text] [Related]
57. Axillary management still needed for patients with sentinel node micrometastases.
Cong BB; Yu JM; Wang YS
Cancer Manag Res; 2019; 11():2097-2100. PubMed ID: 30881133
[TBL] [Abstract][Full Text] [Related]
58. Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial.
Henke G; Knauer M; Ribi K; Hayoz S; Gérard MA; Ruhstaller T; Zwahlen DR; Muenst S; Ackerknecht M; Hawle H; Fitzal F; Gnant M; Mátrai Z; Ballardini B; Gyr A; Kurzeder C; Weber WP
Trials; 2018 Dec; 19(1):667. PubMed ID: 30514362
[TBL] [Abstract][Full Text] [Related]
59. Omission of sentinel node biopsy for breast cancer: Historical context and future perspectives on a modern controversy.
Jatoi I; Kunkler IH
Cancer; 2021 Dec; 127(23):4376-4383. PubMed ID: 34614216
[TBL] [Abstract][Full Text] [Related]
60. Is axillary lymph node clearance required in node-positive breast cancer?
Bundred NJ; Barnes NL; Rutgers E; Donker M
Nat Rev Clin Oncol; 2015 Jan; 12(1):55-61. PubMed ID: 25367714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
